U.S. House · 118th Congress · H.R. 383

H.R. 383

To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Diana HarshbargerR-TN-1
Introduced
January 17, 2023, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (26)

26 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these

Signed on later